Abstract. Somatic Wee1 is a protein kinase that plays a key role in cell cycle progression at the onset of mitosis by phosphorylating CDK1 at the inhibitory Tyr15 amino acid residue. Wee1 is regulated at multiple levels, i.e., phosphorylation, protein-protein association and proteasome-mediated degradation. We have recently shown that the regulatory ß-subunit of protein kinase CK2 participates in PLK1-Wee1 complex formation interacting directly with Wee1 and thereby contributing to the regulation of G2-M cell cycle transition. Here, we show that Wee1 binds CK2ß via two domains comprising amino acids 59-71 and 232-332. By employing deletion mutants of the CK2ß-subunit we also show that two regions between residues 1-5 and 155-170 are necessary for binding Wee1. Furthermore, we demonstrate that the interaction between CK2ß and Wee1 does not modify the kinase activity of the latter, instead CK2ß directly upregulates CDK1 kinase activity by reversing the inhibitory effect which follows Wee1-mediated phosphorylation. Taken together, our findings reinforce the notion that CK2ß is a modulator of protein kinases implicated in cell cycle regulation and exerts functions that are independent of CK2 tetramers.
Introduction
Protein kinase CK2 is a highly conserved enzyme ubiquitously expressed among all the eukaryotic organisms investigated so far. It is composed of two catalytic subunits · and/or ·' and two regulatory ß-subunits. CK2 was originally described as an enzyme characterized by a tetrameric structure but evidence suggests that the individual subunits can exist in association with various intracellular proteins (1, 2) . Because of the broad spectrum of proteins that interact with or are phosphorylated by CK2, it is not surprising that this enzyme is implicated in various intracellular processes ranging from regulation of transcription, DNA replication and repair to survival, proliferation and differentiation (reviewed in refs. 2, 3) . Numerous studies have also suggested that CK2 exerts a vital function. Indeed it was shown by gene knockout experiments in mammals that both the ·-and ß-subunits are essential for the development of mice (4, 5) while lack of expression of the ·'-subunit is not lethal but leads to infertility (6) . CK2 has also been linked to the regulation of cell cycle progression in lower as well as higher eukaryotes (reviewed in refs. 7, 8) .
Cell cycle progression is controlled by numerous proteins which act in order to preserve the integrity of the genetic information crucial for the survival of a cell. Entry into mitosis is mainly regulated by CDK1 whose optimal activation is achieved following the association with cyclin B and phosphorylation in the conserved T-loop domain. During interphase, CDK1 activity is maintained low by phosphorylation of two amino acids residues (i.e., Thr14 and Tyr15) catalyzed by Myt1 and Wee1 protein kinases (9, 10) . Entry into mitosis requires the intervention of the CDC25 dual specificity protein phosphatase family members that catalyze the activating dephosphorylation of CDK1 at the aforementioned amino acid residues (reviewed in ref. 11 ).
Previously, we have shown that the regulatory ß-subunit of CK2 interacts with and up-regulates the checkpoint kinase Chk1 (12) and that the overexpression of CK2ß leads to accelerated degradation of CDC25 mediated by Chk1 (13) . More recently, we have revealed a further regulatory contribution of CK2ß to the G2/M cell cycle transition through the modulation of Wee1 expression. Wee1 activity rises during the S and G2 phases of the cell cycle and declines at the onset of mitosis when full activation of CDK1 is required. The stability of Wee1 is regulated by the CDK1/cyclin B-mediated phosphorylation at Ser123 which creates a phosphodegron recognized by the ß-transducin repeat-containing protein (ß-TrCP) and a docking site for the binding of the polo-like kinase 1 [PLK1, (14, 15) ]. We found that CK2ß participates in the PLK1-Wee1 complex formation and interacts directly with Wee1 (16 Preparation of cell extract, Western blot analysis and immunoprecipitation. Cell pellets were re-suspended in cold lysis buffer (50 mM Tris/HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 10% glycerol, 1 mM DTT, 1 mM Na 3 VO 4 , 30 mM ß-glycerophosphate 10 mM NaF and 100 nM okadaic acid) containing a protease inhibitor cocktail (Roche). Cells were sonicated and subsequently centrifuged at 4˚C for 30 min at 10,000 g. Whole extracts were subjected to SDS-PAGE and subsequently transferred to a PVDF membrane (Bio-Rad).
Protein-antibody complexes were visualized by a chemiluminescence detection system following the manufacturer's guidelines (CDP Star, Applied Biosytems). Cell lysates were also used for immunoprecipitation assays essentially as previously described (17) . Recombinant proteins. Human recombinant CK2·, -·', -ß and CK2ß(1-155) deletion mutant were expressed and purified as previously described (18) . Human recombinant Wee1 (N-terminal GST-tag) was purchased from Calbiochem, histone H1 was from Roche and active recombinant CDK1 in complex with cyclin B was from Millipore.
Antibodies
Kinase assays. In vitro CDK1 kinase assay was performed in the presence of human recombinant CDK1 in complex with cyclin B, histone H1 as a substrate, Wee1 and increasing amounts of either full length CK2ß or the CK2ß(1-155) deletion mutant as indicated in the figure legends. Reaction mixtures were incubated for 30 min at 30˚C in the presence of kinase buffer (50 mM Tris pH 7.4, 10 mM MgCl 2 , 1 mM DTT, 0.1 mM EDTA, 10 mM ß-glycerophosphate, 50 μM ATP and 10 μCi[Á-32 P]ATP). Reactions were stopped by adding SDS-sample buffer and subsequently analyzed by SDS-PAGE and Western blotting. Radioactive protein bands were revealed by autoradiography and the incorporated radioactivity was quantified by scintillation counting (Packard) of the excised radioactive protein bands.
Results

Wee1 kinase predominantly associates with the regulatory ß-subunit of protein kinase CK2. Mapping of the CK2ß binding regions.
We have previously reported that Wee1 kinase interacts with CK2ß in cells transiently transfected with Wee1 and either CK2·' or CK2ß plasmids DNA (19) . In order to further characterize the association between CK2 and Wee1, we have conducted in vitro immunoprecipitation experiments ( Fig. 2C and E indicate that the major region involved in the interaction with Wee1 resides in the C-terminal domain of CK2ß and it is comprised between amino acids 155 and 170 (Fig. 2E ) as mutant CK2ß(1-155)-MycHis failed to interact with Wee1. We also noted that the N-terminal domain of CK2ß contributes to the association with Wee1 as lack of 5 amino acid residues (i.e., mutant CK2ß(5-215)-MycHis) resulted in a weaker but still detectable interaction with Wee1 (Fig. 2C) .
Identification of Wee1 amino acid residues mediating the interaction with CK2ß. In order to identify the Wee1 amino acid residues involved in the association with CK2ß we employed a panel of plasmid DNA constructs expressing various N-and C-terminal Wee1 deletion mutants following transient transfection of Cos-1 cells (Fig. 3A) . Whole extracts from cells co-transfected with CK2ß-MycHis and either of the individual Wee1 constructs were subjected to Western blot analysis. Since the various N-terminal deletion mutants were not equally expressed (i.e., Fig. 3B, lanes 6 and 7) we attempted to normalize their expression levels prior to proceeding with further assays (Fig. 3B, lower panel) . Whole extracts were then subjected to immunoprecipitation with rabbit monoclonal anti-Myc antibody. As shown in Fig. 3C , one of the regions involved in the association with CK2ß mapped between amino acids 59 and 71 as association with CK2ß was still detectable when we employed the ΔN59-Wee1 deletion mutant (lane 5) but not the subsequent one (i.e., ΔN71-Wee1, lane 6). We performed a similar analysis employing a set of C-terminal Wee1 deletion mutants whose expression levels were compared before proceeding with further experiments (Fig. 3D ). Co-immunoprecipitation experiments revealed that a second Wee1 region contributes to the association with CK2ß that is comprised between amino acids 232 and 332 (Fig. 3E) as the Wee1-332 * deletion mutant was still able to associate with CK2ß (lane 7) but not the subsequent Wee1 fragment (i.e., Wee1-232 * , lane 8). Thus, from this analysis we could conclude that two regions are equally important for the binding of Wee1 to CK2ß as the absence of either one destabilizes the association between the aforementioned proteins. It is worth noting that for the immunoprecipitation experiments and the detection of the individual proteins by Western blotting, we employed various antibodies according to the location of the epitopes recognized by the anti-Wee1 antibodies and the Wee1 deletion mutants under investigation. As shown in Fig. 3E , Wee1 was detected with rabbit polyclonal antibody which made it possible to also detect the endogenous Wee1 co-precipitated with CK2ß-MycHis. Wee1 was detected with a mouse monoclonal antibody whose epitope maps in the C-terminal domain of Wee1 (Fig. 3C) . Under the conditions applied for detecting Wee1, this antibody did not promptly reveal the coprecipitated endogenous full length Wee1.
We attempted to confirm the results described above analyzing whole extracts from Cos-1 cells co-transfected with CK2ß-MycHis and full length Wee1 or one of the Wee1 C-terminal deletion mutants which failed to bind CK2ß (i.e., Wee1-215 * ), by gel filtration chromatography (Fig. 4) . Full length Wee1 eluted in three major peaks (Fig. 4A) at positions corresponding to molecular masses in the range of 850-1,600 kDa (i.e., fractions [18] [19] [20] , 230-500 kDa (i.e., fractions 23-25) and 80-130 kDa (i.e., fractions 28-30), respectively. CK2ß-MycHis eluted over a wide range of molecular masses (i.e., fractions 18-30). We then analyzed the elution profile of extracts from cells co-transfected with Wee1-215 * mutant and CK2ß-MycHis (Fig. 4B ). Wee1-215 * eluted in fractions 30 and 31 while endogenous full length Wee1 was present in fractions corresponding to higher molecular masses (i.e., fractions 27 and 28). The elution profile of CK2ß-MycHis was as in Fig. 4A . Next, we performed immunoprecipitation assays using rabbit polyclonal anti-CK2ß and fractions corresponding to the three elution peaks containing full length Wee1. Co-immunoprecipitation of Wee1 and CK2ß-MycHis or the endogenous CK2ß was detected in fractions 18-20 indicative for the presence of high molecular mass complexes (Fig. 4C) . As expected, no association was observed in immunoprecipitation assays employing fractions resulting from the analysis of protein extract derived from cells co-transfected with Wee1-215 * mutant and CK2ß-MycHis (results not shown).
CK2ß binding to Wee1 does not influence the Wee1-mediated inhibitory phosphorylation of CDK1.
Next, we analyzed the functional consequences of the interaction between CK2ß and Wee1. We performed in vitro kinase assays employing human recombinant Wee1, active CDK1/cyclin B complex as Wee1 substrate, and increasing amounts of either full length human recombinant CK2ß (Fig. 5A) or the 1-155 C-terminal deletion mutant (Fig. 5B) . Based on results shown in Figs. 2 and 3, we postulated that the presence of CK2ß bound to Wee1 would reverse the Wee1-mediated inhibition of CDK1 activity. The activity of CDK1 was tested by measuring the incorporation of radioactive phosphate into histone H1. As indicated in Fig. 5A , the presence of Wee1 (lane 5) inhibited the kinase activity of CDK1 about 40% with respect to the control assay (lane 3). By adding increasing amounts of CK2ß to the reaction (lanes 6-9) we observed increasing phosphorylation of histone H1 up to 140% in the presence of 10 pmol CK2ß (lane 9). Moreover, a strong activation of CDK1 was also observed in the presence of 10 pmol CK2ß (lane 4), where the CDK1 activity was twice as high as the control assay (lane 3). Wee1-mediated CDK1 phosphorylation levels at the inhibitory Tyr15 remained unchanged with respect to the control experiment (lane 5) in the presence of CK2ß (lanes 6-9). Experiments conducted with CK2ß(1-155) deletion mutant which was expected not to reverse the Wee1-mediated inhibition of CDK1, led to similar results. Data reported in Fig. 5B , indicate that the association of CK2ß with Wee1 does not affect Wee1-mediated phosphorylation of CDK1 and that the direct interaction between CDK1 and CK2ß reported in Fig. 5C might be responsible for the observed upregulation of CDK1 activity in the presence of CK2ß.
Discussion
Recent evidence has pointed out that the individual subunits of protein kinase may have independent intracellular functions, can be asymmetrically distributed inside the cell and that their expression can be altered in some pathological conditions [e.g., cancer (1, 20) ]. We have recently shown that the regulatory ß-subunit of CK2 regulates the stability of Wee1 kinase 1 and 3) , GST (lane 4) were subjected to immunoprecipitation with a rabbit polyclonal anti-CK2ß antibody.
Immunoprecipitates were subjected to SDS-PAGE and subsequently Western blotting for protein detection by using the indicated antibodies. The detection of GST relative to the control experiment indicated in lane 4 is not shown as no signal was detected.
revealing a novel component of the complex machinery that operates at the G2/M cell cycle transition (16) . In the present study, we attempted to: i) closer investigate the nature of the interaction between Wee1 and the CK2 subunits, ii) map the Wee1 and CK2ß interaction domains and iii) elucidate the functional consequence of their association with respect to Wee1 kinase activity. The usage of recombinant proteins for studying the in vitro interaction between Wee1 and the individual CK2 subunits revealed that Wee1 predominantly binds CK2ß when present in the reaction assay as individual subunit but not as part of the heterotetrameric enzyme thus suggesting that the CK2ß binding regions might be partially masked when CK2ß becomes part of the holoenzyme. The structural mapping for identifying the regions involved in the association with Wee1 led to the interesting observation that not only a C-terminal region located between amino acids 155 and 170 is involved in the binding of Wee1 but also that the lack of the first CK2ß five amino acids partially abolishes the association between the aforementioned proteins. A number of proteins bind either the C-terminal domain, the juxtadimer interface region or the N-terminal region of CK2ß (reviewed in refs. 2, 21) . Interestingly, we found that two CK2ß domains are involved in the association with Wee1. Since the C-terminal region is required for the interaction with the CK2 catalytic subunits and Wee1, this is consistent with the exclusion of CK2· or -·' from the Wee1/CK2ß complex that we have previously described (19) . Analysis of various Wee1 deletion mutants identified that the two regions between amino acids 59-71 and 232-332 are equally important with respect to the interaction with CK2ß as their deletion completely abolishes the association with CK2ß. The region comprising amino acids 232-332 contains a nuclear localization signal (amino acids 252-256), part of the kinase catalytic domain and a Wee1 autophosphorylation site (i.e., Tyr295). By the usage of various deletion mutants we have been able to define the regions involved in the CK2ß/Wee1 association. Since the amino acid sequence spanning from amino acid 232-332 constitutes part of the Wee1 kinase domain we tested whether the presence of CK2ß would affect the kinase activity of Wee1. Results reported in Fig. 5 show that their interaction does not modify the activity of Wee1 with respect to the CDK1 inhibitory phosphorylation at Tyr15. Indeed, we obtained similar results employing a CK2ß deletion mutant unable to bind Wee1. Unexpectedly, we found that the presence of CK2ß in the reaction mixture competes with Wee1 with respect to CDK1 since CK2ß which interacts with CDK1, reverts the activity of CDK1 to the levels observed in the control assays. It is noteworthy that in many respects CK2ß is reminiscent of cyclins with respect to regulation of degradation, ligand specificity, formation of complexes and cell-cycle dependent activity (reviewed in ref. 21) . While the interaction between Wee1 and CK2ß is not affecting the activity of Wee1, it cannot be excluded that their association might influence other Wee1 functions such as its cellular localization. We found, in fact, that one of the two regions mediating the interaction with CK2ß comprises the Wee1 nuclear localization signal. It is tempting to speculate, thus, that under specific conditions the association with CK2ß might affect the migration of Wee1 into the nucleus where it exerts full control of CDK1 activity.
The fact that CK2ß and Wee1 are part of high molecular mass complexes, as suggested by gel filtration analysis, indicates that the binding of CK2ß might have functional consequences for Wee1 as part of the aforementioned intracellular complexes.
In conclusion, in vitro studies have shown that Wee1 preferentially binds to the regulatory ß-subunit of CK2. By using various deletion mutants we have indentified the regions involved in the association between the afore-mentioned proteins. As their association does not modify Wee1 kinase activity with respect to CDK1 phosphorylation, one of the major substrate targets of Wee1, further work will be decisive to ultimately elucidate the effects of CK2ß binding to Wee1 with respect to regulation of cell cycle progression.
